TUCSON, Ariz., Sept. 12, 2016 -- Medicine is being “fundamentally transformed” into an unaffordable, complex, adversarial, depersonalized labyrinth, writes dermatologist Melinda Woofter, M.D., of Granville, Ohio, in the fall issue of the Journal of American Physicians and Surgeons. Dr. Woofter is currently president of the Association of American Physicians and Surgeons (AAPS).
The direct reason for the unsustainable system, she writes, is government distortion of the marketplace, destroying cost transparency: “Government control of resources always leads to less for everyone. Without natural price signals for market adjustments, costs soar as resources are wrongly allocated, wasted, and squandered.”
In an effort to fix the problem it caused, government resorts to further price controls and still more coercion and restrictions, she explains. Solutions are difficult to find because “government powerholders and third-party cronies who benefit from this will not give up their stranglehold on medicine.”
Dr. Woofter recommends a short new primer analyzing the causes of the high costs and deteriorating quality of American medicine: Common Sense Medicine: Restoring the Patient/Physician Relationship by Jeff Danby. The key is not to pass more laws and regulations, but to restore natural price discovery between patients and doctors, Danby writes.
The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS), a national organization representing physicians in all specialties since 1943.
Contact: Jane M. Orient, M.D., (520) 323-3110, janeorientmd@gmail., or Melinda Woofter, M.D., [email protected]


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Instagram Outage Disrupts Thousands of U.S. Users
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



